BioHarvest Sciences Inc. Launches First Major U.S. Marketing Campaign
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – August 18, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) announced the first multi-media campaign for VINIA™ in the United States, Phase 1. The Company is intensifying its marketing in the Unis en is part of a 2022 growth plan that aims for significant growth in orders after commercial entry in 2021.
“We are excited to launch our first integrated marketing campaign aimed at growing our loyal customer base here in the United States,” said CEO Ilan Sobel, in New York for the launch. “Bringing our new 20-tonne production plant online was an integral part of scaling up VINIA™’s global offering, so this marketing launch is testament to the coordinated dedication of the entire VINIA™ team to this. to arrive.”
The initial phase will include television and online advertising with a particular focus on Christian programming, which includes TBN (Trinity Broadcasting Network, the largest religious television network in the world). As part of the sponsorship deal with TBN, Sobel will appear on the network’s flagship shows hosted by Eric Metaxas and Mike Huckabee, with all content to be supported by online advertising and educational content.
New 60-second VINIA™ ads have been created specifically for the TBN campaign, starting August 15, 2022 (See sample here)
The campaign highlights VINIA’s concept of “cellular nutrition” and the benefits of increased blood flow, bringing in Sobel and his own family members.
“I am inspired every day to hear from our community of customers how VINIA™ is improving their health,” said Sobel. “We measure our success by our ability to have a significant positive impact on people’s lives, and as such, the effectiveness of our products is proven not only in clinical trials but also daily with VINIA users.”
See this link for an examination of the impact on three generations of the Sobel family.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing biotechnology company listed on the Canadian Stock Exchange. BioHarvest has developed a patented biocellular growth platform technology capable of cultivating the active and beneficial ingredients of fruits and plants, on an industrial scale, without the need to cultivate the plant itself. This technology is economical, provides consistency and avoids the negative environmental impacts associated with traditional agriculture. BioHarvest is currently focused on the nutraceutical and medicinal cannabis markets. Visit: www.bioharvest.com.
BioHarvest Sciences Inc.
Ilan Sobel, General Manager
For more information, please contact:
Dave Ryan, Vice President of Investor Relations and Director Phone: 1 (604) 622-1186
Email: dave@bioharvest.com
Twitter: https://twitter.com/bioharvestbhsc
Facebook: https://www.facebook.com/BioHarvestSciences
LinkedIn: https://www.linkedin.com/company/bioharvestsciences/
Youtube: https://www.youtube.com/channel/UCGRJWztmLoycsLFWqwXAzAw
Forward-looking statements
The information in this press release includes forward-looking statements based on management’s current estimates, beliefs, intentions and expectations, and is subject to a number of risks and uncertainties that could cause actual results differ materially from those described in the forward-looking statements. There is no guarantee that the strong sales metrics recorded to date will result in future demand or that the proposed additional marketing expenditures will result in increased sales. There can be no assurance that the Company will achieve significant order growth, as this would require the marketing campaign to be successful, which is subject to uncertainties, particularly the response of target audiences to the campaign. Nutraceutical markets are unpredictable and subject to changing consumer tastes and trends as well as economic factors beyond our control. Delays and cost overruns may cause delays in achieving our objectives of obtaining market acceptance, and regulatory approvals for geographic expansion are subject to risk and cannot be guaranteed.
All forward-looking statements are inherently uncertain and actual results may be affected by a number of important factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statements other than through our regular management discussions and analysis.
Neither the Canadian Securities Exchange nor its regulation services provider accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/134209
